earnings
confidence high
sentiment negative
materiality 0.70
Illumina Q2 revenue up 1% to $1.18B, non-GAAP EPS $0.32, ships 109 NovaSeq X; guides FY23 non-GAAP EPS $0.75-0.90
ILLUMINA, INC.
2023-Q2 EPS reported
-$1.46
revenue$2,263,000,000
- Revenue $1.176B (+1% YoY, +8% QoQ); GAAP loss per share $(1.48) vs $(3.40) (incl. $609M legal contingency).
- Non-GAAP diluted EPS $0.32 vs $0.57; non-GAAP gross margin 66.5% vs 69.4%.
- Shipped 109 NovaSeq X instruments in Q2; FY2023 supply capacity now >390 instruments.
- FY2023 guidance: rev growth ~1%, GAAP loss $(2.08)-(1.93), non-GAAP EPS $0.75-$0.90.
- Headwinds: cautious customer spending, slow China recovery, temporary decline in high-throughput consumables.